Comparative Analysis of Epidemiological and Clinical Characteristics Between Invasive Candida Infection versus Colonization in Critically Ill Patients in a Tertiary Hospital in Anhui, China

References

• Leroy O, Bailly S, Gangneux JP, et al. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann Intensive Care. 2016;6(1):2. doi:10.1186/s13613-015-0103-7
   PubMed Web of Science ®Google Scholar
• Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026. doi:10.1038/nrdp.2018.26
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Mohamed AA, Lu XL, Mounmin FA. Diagnosis and treatment of esophageal candidiasis: current updates. Can J Gastroenterol Hepatol. 2019;2019:3585136. doi:10.1155/2019/3585136
   Web of Science ®Google Scholar
• Dichtl K, Seybold U, Wagener J. Serological biomarkers of candidemia: a retrospective evaluation of three assays. Infection. 2019;47(2):217–224. doi:10.1007/s15010-018-1224-3
   Web of Science ®Google Scholar
• Pini P, Bettua C, Orsi CF, et al. Evaluation of serum (1 –> 3)-beta-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors. Infection. 2016;44(2):223–233. doi:10.1007/s15010-015-0849-8
   Web of Science ®Google Scholar
• Lain A, Elguezabal N, Moragues MD, Garcia-Ruiz JC, Del Palacio A, Ponton J. Contribution of serum biomarkers to the diagnosis of invasive candidiasis. Expert Rev Mol Diagn. 2008;8(3):315–325. doi:10.1586/14737159.8.3.315
   Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. Diagnosing invasive candidiasis. J Clin Microbiol. 2018;56(5):e01909–e01917. doi:10.1128/JCM.01909-17
   PubMed Web of Science ®Google Scholar
• Alenazy H, Alghamdi A, Pinto R, Daneman N. Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: a systematic review and meta-analysis. Int J Infect Dis. 2021;102:357–362. doi:10.1016/j.ijid.2020.10.092
   Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov. 2010;9(9):719–727. doi:10.1038/nrd3074
   PubMed Web of Science ®Google Scholar
• Chen J, Li H, Li R, Bu D, Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 2005;55(1):31–37. doi:10.1093/jac/dkh507
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S445–S451. doi:10.1093/infdis/jix131
   PubMed Web of Science ®Google Scholar
• Teo JQ, Lee SJ, Tan AL, et al. Molecular mechanisms of azole resistance in Candida bloodstream isolates. BMC Infect Dis. 2019;19(1):63. doi:10.1186/s12879-019-3672-5
   Web of Science ®Google Scholar
• Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017;10:237–245. doi:10.2147/IDR.S118892
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mert A. Candida urinary tract infections in adults. World J Urol. 2020;38(11):2699–2707. doi:10.1007/s00345-019-02991-5
   PubMed Web of Science ®Google Scholar
• Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg. 1997;84(7):920–935. doi:10.1002/bjs.1800840707
   Web of Science ®Google Scholar
• Ewig S, Schlochtermeier M, Goke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002;121(5):1486–1492. doi:10.1378/chest.121.5.1486
   Web of Science ®Google Scholar
• Zhang L, Xiao M, Wang H, et al. Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China. J Clin Microbiol. 2014;52(2):572–577. doi:10.1128/JCM.02543-13
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 3rd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
   Google Scholar
• Feng W, Yang J, Ma Y, et al. The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles-resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11. Immun Inflamm Dis. 2021;9(3):667–680. doi:10.1002/iid3.415
   PubMed Web of Science ®Google Scholar
• Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother. 2005;49(2):668–679. doi:10.1128/AAC.49.2.668-679.2005
   PubMed Web of Science ®Google Scholar
• Jiang C, Dong D, Yu B, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68(4):778–785. doi:10.1093/jac/dks481
   PubMed Web of Science ®Google Scholar
• Feng LJ, Wan Z, Wang XH, Li RY, Liu W. Cloning and bioinformatic analysis of ERG11 gene in Candida parapsilosis. Chin J Mycol. 2010;5(2):92–96.
   Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. Swiss-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–W303. doi:10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Keniya MV, Sabherwal M, Wilson RK, et al. Crystal structures of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery. Antimicrob Agents Chemother. 2018;62(11):e1134–e1138. doi:10.1128/AAC.01134-18
   PubMed Web of Science ®Google Scholar
• Larone DH. Medically Important Fungi: A Guide to Identification. 5th ed. Washington DC: ASM Press; 2011.
   Google Scholar
• Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICUSGoI. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med. 2011;39(4):665–670. doi:10.1097/CCM.0b013e318206c1ca
   PubMed Web of Science ®Google Scholar
• Diba K, Makhdoomi K, Nasri E, et al. Emerging Candida species isolated from renal transplant recipients: species distribution and susceptibility profiles. Microb Pathog. 2018;125:240–245. doi:10.1016/j.micpath.2018.09.026
   Web of Science ®Google Scholar
• Vaezi A, Fakhim H, Khodavaisy S, et al. Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis. J Mycol Med. 2017;27(2):146–152. doi:10.1016/j.mycmed.2017.02.007
   PubMed Web of Science ®Google Scholar
• Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305. doi:10.1111/j.1574-6976.2011.00278.x
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Dannaoui E, et al. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses. 2018;61(6):377–382. doi:10.1111/myc.12754
   PubMed Web of Science ®Google Scholar
• Xiao Z, Wang Q, Zhu F, An Y. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control. 2019;8(1):89. doi:10.1186/s13756-019-0534-2
   PubMed Web of Science ®Google Scholar
• Enoch DA, Yang H, Aliyu SH, Micallef C. The changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017;1508:17–65. doi:10.1007/978-1-4939-6515-1_2
   PubMedGoogle Scholar
• Gonzalez GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol. 2008;46(9):2902–2905. doi:10.1128/JCM.00937-08
   PubMed Web of Science ®Google Scholar
• Kourkoumpetis T, Manolakaki D, Velmahos G, et al. Candida infection and colonization among non-trauma emergency surgery patients. Virulence. 2010;1(5):359–366. doi:10.4161/viru.1.5.12795
   PubMed Web of Science ®Google Scholar
• Manolakaki D, Velmahos G, Kourkoumpetis T, et al. Candida infection and colonization among trauma patients. Virulence. 2010;1(5):367–375. doi:10.4161/viru.1.5.12796
   PubMed Web of Science ®Google Scholar
• Wang B, He X, Lu F, et al. Candida isolates from blood and other normally sterile foci from ICU patients: determination of epidemiology, antifungal susceptibility profile and evaluation of associated risk factors. Front Public Health. 2021;9:779590. doi:10.3389/fpubh.2021.779590
   PubMed Web of Science ®Google Scholar
• Zhang W, Song X, Wu H, Zheng R. Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans candidaemia in adult patients in Northeast China. Epidemiol Infect. 2019;147:e277. doi:10.1017/S0950268819001638
   PubMed Web of Science ®Google Scholar
• Holley A, Dulhunty J, Blot S, et al. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int J Antimicrob Agents. 2009;33(6):554e1–554e7. doi:10.1016/j.ijantimicag.2008.10.035
   Web of Science ®Google Scholar
• Goncalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905–927. doi:10.3109/1040841X.2015.1091805
   PubMed Web of Science ®Google Scholar
• Charles PE, Dalle F, Aube H, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393–400. doi:10.1007/s00134-005-2571-y
   Web of Science ®Google Scholar
• Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest. 2003;124(6):2244–2255. doi:10.1378/chest.124.6.2244
   PubMed Web of Science ®Google Scholar
• Ma CF, Li FQ, Shi LN, et al. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China. BMC Infect Dis. 2013;13:337. doi:10.1186/1471-2334-13-337
   PubMed Web of Science ®Google Scholar
• Li F, Wu L, Cao B, Zhang Y, Li X, Liu Y. Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011. BMC Infect Dis. 2013;13(1):353. doi:10.1186/1471-2334-13-353
   Web of Science ®Google Scholar
• Zeng ZR, Tian G, Ding YH, Yang K, Liu JB, Deng J. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China. BMC Infect Dis. 2019;19(1):939. doi:10.1186/s12879-019-4588-9
   PubMed Web of Science ®Google Scholar
• Guo LN, Yu SY, Xiao M, et al. Species distribution and antifungal susceptibility of invasive candidiasis: a 2016-2017 multicenter surveillance study in Beijing, China. Infect Drug Resist. 2020;13:2443–2452. doi:10.2147/IDR.S255843
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–50. doi:10.1093/cid/civ933
   PubMed Web of Science ®Google Scholar
• Arendrup MC. Update on antifungal resistance in Aspergillus and Candida. Clin Microbiol Infect. 2014;20(Suppl. 6):42–48. doi:10.1111/1469-0691.12513
   PubMed Web of Science ®Google Scholar
• Kelly SL, Lamb DC, Kelly DE. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol Lett. 1999;180(2):171–175. doi:10.1111/j.1574-6968.1999.tb08792.x
   PubMed Web of Science ®Google Scholar
• Fan X, Xiao M, Zhang D, et al. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Clin Microbiol Infect. 2019;25(7):885–891. doi:10.1016/j.cmi.2018.11.007
   PubMed Web of Science ®Google Scholar
• Wang H, Kong F, Sorrell TC, et al. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiol. 2009;9:167. doi:10.1186/1471-2180-9-167
   Web of Science ®Google Scholar